Article
Bristol Myers CEO Caforio takes pay cut as 'human capital' metric drags down bonus
Rating:
0.0
Views:
52
Likes:
1
Library:
1
Bristol Myers Squibb is hoping new launches will offset a wave of forthcoming patent losses for some of its biggest-selling drugs. | Bristol Myers Squibb is hoping new launches will offset a wave of forthcoming patent losses for some of its biggest-selling drugs. But in the meantime, CEO Giovanni Caforio just received a smaller pay package.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value